Staffing Mandates Boost Care Without Closing Nursing Homes
New Evidence Undercuts Industry Warnings and Supports the Case To Restore Federal Minimum Staffing Standards
Improving Care for Older Adults
In Their Own Words
Lessons from Landmark Drug Revolutions for the Future of Alzheimer’s Treatment
An LDI Fellow Draws on Historic, Paradigm-Shifting Treatments in Depression and Obesity to Consider What Meaningful Breakthroughs in Dementia Care Could Look Like
Print:
This essay originally appeared in STAT News on December 22, 2025 as part of the Neurotransmissions column.
In the weeks leading up to Dec. 3, I imagined a fantastic headline: “Ozempic treats Alzheimer’s disease.”
On that day, at the CtAD 2025 meeting (CtAD stands for Clinical Trials in Alzheimer’s Disease), in the Sapphire Ballroom of the Hilton San Diego Bayfront hotel, Novo Nordisk would present to the assembly of scientists and biopharma executives the results of its EVOKE studies, two clinical trials testing whether semaglutide can treat people with early-stage symptomatic Alzheimer’s disease. Semaglutide is, of course, the chemical name for the brand Ozempic, FDA labeled for the treatment of diabetes and to reduce the risk of major cardiovascular events, but widely known as a drug for obesity.
Read the full essay here.
Author
Jason Karlawish, MD
Professor, Medicine and Professor, Medical Ethics and Health Policy, Perelman School of Medicine; Co-Director, Penn Memory Center
More on Improving Care for Older Adults
The Long-Term Care Experiment Everyone is Watching
Washington State’s First-in-the-Nation Insurance Plan Begins Payouts in Mid-2026, and Researchers Will Weigh its Effect on Care, Costs, and the Long-Term Care Markets
Medicaid Long-Term Services and Supports Data
Issue Brief: Understanding Gaps and Opportunities to Advance Research and Policy
Toward a More Humane and Economically Viable Long-Term Care System
A Penn LDI Virtual Panel Looks Ahead at New Possibilities
Reforming Long-Term Care Policy
Lessons from the Past, Imperatives for the Future
The Moral Quandary of Tech-Enabled Caregiving
Technology Helps Older Adults Stay at Home—But May Delay Necessary Transitions to Higher Levels of Care